SK Holdings, the holding company of South Korea's SK Group, has established SK pharmteco, a U.S.-based contract manufacturing organization (CMO) supporting pharmaceutical customers worldwide.
Dr. Jeong Woo Cho was appointed president and CEO of SK Biopharmaceuticals and SK Life Sciences, leading the company into the next phase of development.